Next Article in Journal
A Primer on the Genetics of Medullary Thyroid Cancer
Previous Article in Journal
Patient–Physician Discordance in Goals of Care for Patients with Advanced Cancer
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Recurrence and Mortality after Breast-Conserving Surgery without Radiation

1
MaRS Centre, Princess Margaret Cancer Centre, 101 College Street, Room 5-535, Toronto, ON M5G 1L7, Canada
2
Department of Surgery, University of Toronto, Toronto, ON, Canada
3
Schulich School of Medicine and Dentistry, Western University, London, ON, Canada
4
London Health Sciences Centre, London, ON, Canada
5
ICES, London, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2019, 26(6), 380-388; https://doi.org/10.3747/co.26.5225
Submission received: 5 September 2019 / Revised: 4 October 2019 / Accepted: 2 November 2019 / Published: 1 December 2019

Abstract

Background: Breast-conserving surgery (BCS) and radiation therapy (RT) are the standard of care for early breast cancer; studies have demonstrated that adjuvant RT confers a protective effect with respect to recurrence, although no randomized trials have shown a survival benefit. Methods: This retrospective cohort study used Ontario data linked through ICES to examine patients treated for breast cancer between 1 April 2007 and 31 March 2014. The primary outcome was death or recurrence. Outcomes were compared between patients who did and did not receive RT. Results: The total cohort size was 26,279. The hazard ratios (HRS) for various outcomes were significantly higher for patients who did not receive RT than for patients who did: recurrence or death combined [HR: 2.49; 95% confidence interval (CI): 2.25 to 2.75], recurrence (HR: 2.33; 95% CI: 1.91 to 2.84), and death (HR: 2.28; 95% CI: 2.03 to 2.56). The HR for death was 1.81 (95% CI: 1.65 to 1.99) for patients having stage II cancer compared with those having stage I disease. The HR for death was 1.97 (95% CI: 1.74 to 2.22) for patients having high comorbidity compared with those having little comorbidity. Conclusions: Adjuvant RT carries a protective effect with respect to recurrence and survival in patients with early-stage breast cancer. That survival benefit has not been appreciated in previous randomized trials and underscores the importance of rt as a component of breast cancer treatment.
Keywords: breast cancer; radiation therapy; death; recurrence; breast-conserving therapy breast cancer; radiation therapy; death; recurrence; breast-conserving therapy

Share and Cite

MDPI and ACS Style

Guidolin, K.; Lock, M.; Vogt, K.; McClure, J.A.; Winick-Ng, J.; Vinden, C.; Brackstone, M. Recurrence and Mortality after Breast-Conserving Surgery without Radiation. Curr. Oncol. 2019, 26, 380-388. https://doi.org/10.3747/co.26.5225

AMA Style

Guidolin K, Lock M, Vogt K, McClure JA, Winick-Ng J, Vinden C, Brackstone M. Recurrence and Mortality after Breast-Conserving Surgery without Radiation. Current Oncology. 2019; 26(6):380-388. https://doi.org/10.3747/co.26.5225

Chicago/Turabian Style

Guidolin, K., M. Lock, K. Vogt, J. A. McClure, J. Winick-Ng, C. Vinden, and M. Brackstone. 2019. "Recurrence and Mortality after Breast-Conserving Surgery without Radiation" Current Oncology 26, no. 6: 380-388. https://doi.org/10.3747/co.26.5225

APA Style

Guidolin, K., Lock, M., Vogt, K., McClure, J. A., Winick-Ng, J., Vinden, C., & Brackstone, M. (2019). Recurrence and Mortality after Breast-Conserving Surgery without Radiation. Current Oncology, 26(6), 380-388. https://doi.org/10.3747/co.26.5225

Article Metrics

Back to TopTop